Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Application of genome-wide expression analysis to human health and disease.

Cobb JP, Mindrinos MN, Miller-Graziano C, Calvano SE, Baker HV, Xiao W, Laudanski K, Brownstein BH, Elson CM, Hayden DL, Herndon DN, Lowry SF, Maier RV, Schoenfeld DA, Moldawer LL, Davis RW, Tompkins RG, Baker HV, Bankey P, Billiar T, Brownstein BH, Calvano SE, Camp D, Chaudry I, Cobb JP, Davis RW, Elson CM, Freeman B, Gamelli R, Gibran N, Harbrecht B, Hayden DL, Heagy W, Heimbach D, Herndon DN, Horton J, Hunt J, Laudanski K, Lederer J, Lowry SF, Maier RV, Mannick J, McKinley B, Miller-Graziano C, Mindrinos MN, Minei J, Moldawer LL, Moore E, Moore F, Munford R, Nathens A, O'keefe G, Purdue G, Rahme L, Remick D, Sailors M, Schoenfeld DA, Shapiro M, Silver G, Smith R, Stephanopoulos G, Stormo G, Tompkins RG, Toner M, Warren S, West M, Wolfe S, Xiao W, Young V; Inflammation and Host Response to Injury Large-Scale Collaborative Research Program.

Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4801-6. Epub 2005 Mar 21.

2.

Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients.

Heagy W, Nieman K, Hansen C, Cohen M, Danielson D, West MA.

Surg Infect (Larchmt). 2003 Summer;4(2):171-80.

PMID:
12906717
3.

Relative hyperoxia augments lipopolysaccharide-stimulated cytokine secretion by murine macrophages.

Danielson DS, Heagy W, Nieman KM, West MA.

Surgery. 2003 May;133(5):538-46.

PMID:
12773982
4.
5.

Endotoxin tolerance: A review.

West MA, Heagy W.

Crit Care Med. 2002 Jan;30(1 Supp):S64-S73.

PMID:
11891406
6.

Endotoxin tolerance: a review.

West MA, Heagy W.

Crit Care Med. 2002 Jan;30(1 Suppl):S64-73. Review.

PMID:
11782563
7.

Impaired mitogen-activated protein kinase activation and altered cytokine secretion in endotoxin-tolerant human monocytes.

Heagy W, Hansen C, Nieman K, Rodriguez JL, West MA.

J Trauma. 2000 Nov;49(5):806-14.

PMID:
11086768
8.

Impaired ex vivo lipopolysaccharide-stimulated whole blood tumor necrosis factor production may identify "septic" intensive care unit patients.

Heagy W, Hansen C, Nieman K, Cohen M, Richardson C, Rodriguez JL, West MA.

Shock. 2000 Sep;14(3):271-6; discussion 276-7.

PMID:
11028542
9.

Enkephalin receptors and receptor-mediated signal transduction in cultured human lymphocytes.

Heagy W, Teng E, Lopez P, Finberg RW.

Cell Immunol. 1999 Jan 10;191(1):34-48.

PMID:
9918685
10.

Dual signal transduction through delta opioid receptors in a transfected human T-cell line.

Sharp BM, Shahabi NA, Heagy W, McAllen K, Bell M, Huntoon C, McKean DJ.

Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8294-9.

11.

Beta-endorphin enhances Concanavalin-A-stimulated calcium mobilization by murine splenic T cells.

Shahabi NA, Heagy W, Sharp BM.

Endocrinology. 1996 Aug;137(8):3386-93.

PMID:
8754765
12.

Enkephalins stimulate leukemia cell migration and surface expression of CD9.

Heagy W, Duca K, Finberg RW.

J Clin Invest. 1995 Sep;96(3):1366-74.

13.

Opioid receptor agonists and Ca2+ modulation in human B cell lines.

Heagy W, Shipp MA, Finberg RW.

J Immunol. 1992 Dec 15;149(12):4074-81.

PMID:
1334111
14.

Inhibition of immune functions by antiviral drugs.

Heagy W, Crumpacker C, Lopez PA, Finberg RW.

J Clin Invest. 1991 Jun;87(6):1916-24.

15.

Neurohormones regulate T cell function.

Heagy W, Laurance M, Cohen E, Finberg R.

J Exp Med. 1990 May 1;171(5):1625-33.

16.

Use of IFN-gamma in patients with AIDS.

Heagy W, Groopman J, Schindler J, Finberg R.

J Acquir Immune Defic Syndr. 1990;3(6):584-90.

PMID:
2110972
17.

Recombinant human gamma interferon enhances in vitro activation of lymphocytes isolated from patients with acquired immunodeficiency syndrome.

Heagy W, Strom TB, Kelley VE, Collela J, Crumpacker C, Williams JM, Shapiro HM, Laubenstein L, Finberg R.

Infect Immun. 1989 Nov;57(11):3619-28.

20.
21.

Potent ability of anti-LFA-1 monoclonal antibody to prolong allograft survival.

Heagy W, Waltenbaugh C, Martz E.

Transplantation. 1984 May;37(5):520-3. No abstract available.

PMID:
6427995
22.
23.

The mechanism of CTL-mediated killing: monoclonal antibody analysis of the roles of killer and target-cell membrane proteins.

Martz E, Heagy W, Gromkowski SH.

Immunol Rev. 1983;72:73-96. Review. No abstract available.

PMID:
6347869
24.

Structural and conformational properties of peptides interacting with the glutathione receptor of hydra.

Cobb MH, Heagy W, Danner J, Lenhoff HM, Marshall GR.

Mol Pharmacol. 1982 May;21(3):629-36.

PMID:
6287199
26.

Interaction of glutathione analogues with Hydra attenuata gamma-glutamyltransferase.

Danner J, Cobb MH, Heagy W, Lenhoff HM, Marshall GR.

Biochem J. 1978 Nov 1;175(2):547-53.

27.

Affinity chromatography of glutathione reductase: bound by immobilized GSSG, eluted by NADPH.

Danner J, Lenhoff HM, Heagy W.

Anal Biochem. 1977 Oct;82(2):586-90. No abstract available.

PMID:
20818
28.

Aquatic invertebrates: model systems for study of receptor activation and evolution of receptor proteins.

Lenhoff HM, Heagy W.

Annu Rev Pharmacol Toxicol. 1977;17:243-58. Review. No abstract available.

PMID:
17353
29.

gamma-Glutamyl transpeptidase in Hydra.

Danner J, Lenhoff HM, Houston-Cobb M, Heagy W, Marshall GR.

Biochem Biophys Res Commun. 1976 Nov 8;73(1):180-6. No abstract available.

PMID:
11797

Supplemental Content

Support Center